Wolf administration issues 13 grower/processor permits for Phase II of state’s Medical Marijuana Program

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

HARRISBURG — The Wolf administration announced Tuesday that 13 entities received grower/processor permits for Phase II of the state’s Medical Marijuana Program.

“In Phase I of the program, we built a framework to give patients access to medical marijuana,” Dr. Levine said. “In this next phase, Phase II, we are fully implementing the program to expand access to this medication to every part of the state. This medication is vital to Pennsylvanians suffering from one of the 21 serious medical conditions allowed under the law and we need to ensure they have access to it close to their homes.”

The department has made applicant information, score cards and a table of the Phase II grower/processor permittees available at www.medicalmarijuana.pa.gov.

The 13 permits were issued to:

Highest Scoring
PennAlt Organics Inc

Southeast Region
DocHouse LLC
Agri-Kind LLC

Northeast Region
Pier Cove LLC
PharmaCann Penn Plant LLC

Southcentral Region
Green Leaf Medicals, LLC
Whole Plants LLC

Northcentral Region
Parea BioSciences, LLC

Southwest Region
Maitri Genetics, LLC
Hanging Gardens LLC

Northwest Region
Calypso Enterprises, LLC
FarmaceuticalRx, LLC

The Department anticipated making redacted Phase II grower/processor permittee applications available by November 2018. The Department anticipates making all remaining Phase II redacted grower/processor applications available at a later date.

More than 52,000 patients have registered to participate in the medical marijuana program, and more than 30,000 of those patients have received their identification cards and are able to visit a dispensary to purchase medical marijuana. More than 1,000 physicians have registered for the program and, of those, more than 700 have been approved as practitioners.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.